Lineage Cell Therapeutics, Inc. (LCTX)
1.09
+0.01
(+0.93%)
USD |
NYAM |
Sep 08, 16:00
1.10
+0.01
(+0.92%)
After-Hours: 07:30
Lineage Cell Therapeutics Market Cap : 275.67M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 275.67M |
| September 04, 2026 | 273.14M |
| September 03, 2026 | 278.20M |
| September 02, 2026 | 280.73M |
| September 01, 2026 | 273.14M |
| August 31, 2026 | 278.20M |
| August 28, 2026 | 280.73M |
| August 27, 2026 | 293.37M |
| August 26, 2026 | 283.26M |
| August 25, 2026 | 285.79M |
| August 24, 2026 | 275.67M |
| August 21, 2026 | 273.14M |
| August 20, 2026 | 273.14M |
| August 19, 2026 | 278.20M |
| August 18, 2026 | 268.08M |
| August 17, 2026 | 268.08M |
| August 14, 2026 | 270.61M |
| August 13, 2026 | 268.08M |
| August 12, 2026 | 278.20M |
| August 11, 2026 | 283.26M |
| August 10, 2026 | 285.79M |
| August 07, 2026 | 278.20M |
| August 06, 2026 | 285.79M |
| August 05, 2026 | 288.31M |
| August 04, 2026 | 283.26M |
| Date | Value |
|---|---|
| August 03, 2026 | 276.72M |
| July 31, 2026 | 269.24M |
| July 30, 2026 | 276.72M |
| July 29, 2026 | 264.26M |
| July 28, 2026 | 266.75M |
| July 27, 2026 | 256.78M |
| July 24, 2026 | 256.78M |
| July 23, 2026 | 266.75M |
| July 22, 2026 | 276.72M |
| July 21, 2026 | 284.20M |
| July 20, 2026 | 274.23M |
| July 17, 2026 | 289.19M |
| July 16, 2026 | 291.68M |
| July 15, 2026 | 304.14M |
| July 14, 2026 | 304.14M |
| July 13, 2026 | 301.65M |
| July 10, 2026 | 319.10M |
| July 09, 2026 | 321.59M |
| July 08, 2026 | 334.06M |
| July 07, 2026 | 329.07M |
| July 06, 2026 | 331.57M |
| July 02, 2026 | 336.55M |
| July 01, 2026 | 324.09M |
| June 30, 2026 | 326.58M |
| June 29, 2026 | 336.55M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 316.63M |
| Amgen, Inc. | 212.55B |
| Anika Therapeutics, Inc. | 281.58M |
| BioCryst Pharmaceuticals, Inc. | 2.314B |
| Imunon, Inc. | 7.185M |
Market Cap Related Metrics
| PS Ratio | 20.72 |
| PEG Ratio | -6.353 |
| Price to Book Value | 4.526 |
| Price | 1.09 |
| Earnings Yield | -16.91% |
| PEGY Ratio | -6.353 |